1. Home
  2. IESC vs ASND Comparison

IESC vs ASND Comparison

Compare IESC & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IES Holdings Inc.

IESC

IES Holdings Inc.

HOLD

Current Price

$656.00

Market Cap

13.2B

Sector

Industrials

ML Signal

HOLD

Logo Ascendis Pharma A/S

ASND

Ascendis Pharma A/S

HOLD

Current Price

$220.81

Market Cap

14.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IESC
ASND
Founded
1997
2006
Country
United States
Denmark
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
14.5B
IPO Year
1997
2014

Fundamental Metrics

Financial Performance
Metric
IESC
ASND
Price
$656.00
$220.81
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
16
Target Price
$458.00
$281.50
AVG Volume (30 Days)
198.9K
498.3K
Earning Date
05-01-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
51.87
N/A
EPS
9.95
N/A
Revenue
$3,371,468,000.00
N/A
Revenue This Year
$22.20
$96.35
Revenue Next Year
$14.88
$44.91
P/E Ratio
$70.06
N/A
Revenue Growth
16.89
N/A
52 Week Low
$250.84
$161.09
52 Week High
$713.82
$250.74

Technical Indicators

Market Signals
Indicator
IESC
ASND
Relative Strength Index (RSI) 53.45 39.90
Support Level $347.60 $215.18
Resistance Level $700.20 $236.58
Average True Range (ATR) 33.91 8.08
MACD -4.70 -1.49
Stochastic Oscillator 48.06 9.62

Price Performance

Historical Comparison
IESC
ASND

About IESC IES Holdings Inc.

IES Holdings Inc owns and manages subsidiaries that design and installs integrated electrical and technology systems and provide infrastructure products and services. It has four business segments; Communications, Residential, Infrastructure Solutions, and Commercial & Industrial. The majority of the revenue for the company is generated from its Residential segment in which the company provides electrical installation services for single-family housing and multi-family apartment complexes, as well as heating, ventilation, and air conditioning (HVAC) and plumbing installation services. This segment also provides services for installing residential solar power, both for new construction and existing residences.

About ASND Ascendis Pharma A/S

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.

Share on Social Networks: